Hjem › Type 2-diabetes › Kentucky
Type 2-diabetes kliniske forsøg i Kentucky
12 studier for Type 2-diabetes søger deltagere på steder i Kentucky.
Byer i Kentucky
Officiel studietekst (engelsk)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Qualmedica Research - Bowling Green, Bowling Green
- The Research Group of Lexington, Lexington
- Research Integrity, LLC, Owensboro
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07064473A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- AMR Lexington, Lexington
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07754461A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- St Elizabeth Health Care - CRI, Edgewood
- UofL Health, Louisville
RekruttererFrivillige med god helbredstilstand velkomne
Alder 55 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT06112418A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Monroe Biomedical Research, Louisville
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07595549A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Bowling Green
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07662213Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- St. Elizabeth Healthcare, Edgewood
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07296484AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- The Research Group of Lexington LLC, Lexington
RekruttererFase 3
Alder 45 og opefter · Alle køn · Opdateret 1. sep. 2026 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Lexington
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 31. aug. 2026 · NCT07662044A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Norton Children's Endocrinology, Louisville
RekruttererFase 3
Alder 10 til 17 · Alle køn · Opdateret 7. aug. 2026 · NCT06739122Time-restricted Eating for Patients With Type 2 Diabetes
- University of Kentucky Barnstable Brown Diabetes Center, Lexington
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 31. jul. 2026 · NCT07318207OASIS: Peer Support for T2DM in Appalachia (Peer Participant)
- Barren River Area Development District, Bowling Green
- UK HealthCare, Hazard
Rekrutterer
Alder 55 og opefter · Alle køn · Opdateret 17. jun. 2026 · NCT06336122OASIS: Peer Support for T2DM in Appalachia (Peer Coaches)
- Barren River Area Development District, Bowling Green
- UK HealthCare, Hazard
Rekrutterer
Alder 55 og opefter · Alle køn · Opdateret 17. jun. 2026 · NCT06003634Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.